JANESVILLE, Wis.--(BUSINESS WIRE)--SHINE Medical Technologies LLC today announced that it has closed a $150-million Series C-5 financing. Koch Disruptive Technologies (KDT) led the round, which also ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The funds are in support of ...
JANESVILLE, Wis., May 6, 2025 /PRNewswire/ -- SHINE Technologies, a nuclear fusion company with a platform of medical isotope products, announced it has entered into a definitive agreement to acquire ...
Collaboration enables access to SHINE’s supply of lutetium-177 for Nucleus RadioPharma’s radioligand therapy for neuroendocrine tumors and prostate cancer ROCHESTER, Minn. & JANESVILLE, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Shine Technologies has made a ...
Jun. 30—JANESVILLE — SHINE Medical Technologies announced Tuesday it has received a major, $150 million boost as it moves toward completion and commercialization of its Janesville medical nuclear ...
BEDFORD, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians ...
BEDFORD, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc., the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results